Sign In
Buy NVO
$47.42
+1.52 (+3.31%)
At Close: Jun 23, 2026
Assetmark Inc. Acquires 24,425 Shares of Novo Nordisk A/S $NVO
04:14am, Monday, 16'th Feb 2026
Assetmark Inc. increased its holdings in Novo Nordisk A/S (NYSE: NVO) by 11.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commis
Advisors Asset Management Inc. Sells 13,960 Shares of Novo Nordisk A/S $NVO
03:23am, Monday, 16'th Feb 2026
Advisors Asset Management Inc. lowered its holdings in Novo Nordisk A/S (NYSE: NVO) by 24.5% during the undefined quarter, according to the company in its most recent filing with the Securities and Ex
Ameritas Advisory Services LLC Has $1.08 Million Stock Position in Novo Nordisk A/S $NVO
04:03am, Sunday, 15'th Feb 2026
Ameritas Advisory Services LLC increased its stake in shares of Novo Nordisk A/S (NYSE: NVO) by 289.4% during the third quarter, according to its most recent disclosure with the Securities and Exchang
Got $500? 2 Pharma Stocks to Buy and Hold Forever.
07:45am, Saturday, 14'th Feb 2026
Stocks in the healthcare sector can often serve as a hedge against broader market volatility. But there are also some high-flying growth stocks, particularly within the pharmaceutical and biotech indu
Weekend Morning Brew: AI Jitters, Novo--Hims Clash, McDonald's Beat
07:37am, Saturday, 14'th Feb 2026
Weekly Market HighlightsWeekly breadth was slightly negative with 4,703 advancers versus 4,832 decliners, even as 963 stocks gained more than 10% and 1,151 fel
Hims & Hers Falls Over 50% as Novo Files Obesity Lawsuit
02:08pm, Friday, 13'th Feb 2026
Short sellers are pressing their advantage in Hims and Hers Health (HIMS) as legal overhang reshapes the narrative around its weight-loss push. The shares have fa
Novo Nordisk CEO on medicare coverage, new obesity pill, U.S. pricing pressure
10:00am, Friday, 13'th Feb 2026
Novo Nordisk CEO Mike Doustdar tells CNBC that Medicare coverage for obesity treatments, as well as the launch of a new obesity pill, should help boost prescription volumes and offset lower prices. Ch
First Look: Tech-led selloff, tariff shifts, AI funding boom
07:38am, Friday, 13'th Feb 2026
Stock News Tech slump hits indexes: A broad risk-off move saw Apple (AAPL) and Cisco (CSCO) lead declines, while Applied Materials (AMAT) rallied on upbeat AI t
Novo's Wegovy pill tracks over 38,000 prescriptions in fifth week
07:33am, Friday, 13'th Feb 2026
Novo Nordisk's Wegovy pill hit 38,220 U.S. prescriptions in the fifth week after its launch, IQVIA data shared by an analyst on Friday showed.
Prices, pipelines and patent cliffs: Inside pharma's big reset
06:13am, Friday, 13'th Feb 2026
Pharma earnings weren't the main focus for drugmakers this quarter. "2025 was about understanding kind of the rules of the future of the game," McKinsey Senior Partner Greg Graves told CNBC.
US could take action including fines against Hims after brief Wegovy copy launch
06:05am, Friday, 13'th Feb 2026
The Trump administration could take action including an injunction or fines against online telehealth company Hims for intending to sell a compounded version of Novo Nordisk's Wegovy weight-loss pill,
Market Today: Tech Sells Off on AI Jitters; M&A, FDA Moves and Policy Shifts
05:35pm, Thursday, 12'th Feb 2026
Guru Stock PicksAl Gore has made the following transactions:Reduce in NTNX by 46.77%Sold out in MCHPAdd in MELI by 2.52%New position in CSLKen Fisher has made t
Novo Nordisk plans Wegovy vials amid obesity-drug competition
01:15pm, Thursday, 12'th Feb 2026
Novo Nordisk (NYSE:NVO) announced that it is planning to introduce its weight-loss medication Wegovy in vials. “We are exploring various device presentations for Wegovy, including vials—some are l
Novo Nordisk Plans Wegovy Vial Launch To Counter Eli Lilly, Target Broader Obesity Market
01:02pm, Thursday, 12'th Feb 2026
Novo Nordisk A/S (NYSE: NVO) plans to start selling its blockbuster obesity drug Wegovy in vials, marking its latest effort to strengthen its position against rival Eli Lilly and Co. (NYSE: LLY) as co
Novo Nordisk plans Wegovy vials amid obesity-drug competition
08:14am, Thursday, 12'th Feb 2026
Novo Nordisk (NYSE:NVO) announced that it is planning to introduce its weight-loss medication Wegovy in vials. “We are exploring various device...
